The company reported consolidated revenues of $3.420 billion, operating income of $506 million (adjusted operating income of $517 million), and diluted earnings per share of $2.04 (adjusted diluted earnings per share of $2.51) for the quarter ended September 30 in Q3 2025.

1. 01

   The company reported consolidated revenues of $3.420 billion, operating income of $506 million (adjusted operating income of $517 million), and diluted earnings per share of $2.04 (adjusted diluted earnings per share of $2.51) for the quarter ended September 30 in Q3 2025.

2. 02

   The company said operating cash flow was $842 million and free cash flow was $604 million in Q3 2025. Its full-year free cash flow outlook, both prior and current, is $1,000 million to $1,250 million.

3. 03

   DaVita said it refinanced its existing Term Loan B-1 in July 2025 with a new Term Loan B-2 of $1.9 billion. It also said it repurchased 3.3 million shares in Q3 at an average price of $140.67 per share, for a total of $465 million. The board increased the company's repurchase authorization by $2.0 billion, effective August 21.

4. 04

   The company said its current full-year 2025 outlook calls for adjusted operating income of $2,035 million to $2,135 million and adjusted diluted earnings per share of $10.35 to $11.15. Its prior outlook was $2,010 million to $2,160 million and $10.20 to $11.30, respectively.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.